ES2347754B8 - Suspension oral de lisinato de ibuprofeno - Google Patents

Suspension oral de lisinato de ibuprofeno Download PDF

Info

Publication number
ES2347754B8
ES2347754B8 ES200901093A ES200901093A ES2347754B8 ES 2347754 B8 ES2347754 B8 ES 2347754B8 ES 200901093 A ES200901093 A ES 200901093A ES 200901093 A ES200901093 A ES 200901093A ES 2347754 B8 ES2347754 B8 ES 2347754B8
Authority
ES
Spain
Prior art keywords
oral suspension
ibuprophene
lisinate
ibuprofen
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200901093A
Other languages
English (en)
Other versions
ES2347754B1 (es
ES2347754A1 (es
Inventor
Maite Tarre Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio de Aplicaciones Farmacodinamicas SA
Original Assignee
Laboratorio de Aplicaciones Farmacodinamicas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200901093A priority Critical patent/ES2347754B8/es
Application filed by Laboratorio de Aplicaciones Farmacodinamicas SA filed Critical Laboratorio de Aplicaciones Farmacodinamicas SA
Priority to CN2010800226440A priority patent/CN102448499A/zh
Priority to US13/266,730 priority patent/US20120101159A1/en
Priority to PCT/ES2010/000185 priority patent/WO2010125212A1/es
Priority to TW099113307A priority patent/TW201038296A/zh
Priority to JP2012507789A priority patent/JP5977672B2/ja
Publication of ES2347754A1 publication Critical patent/ES2347754A1/es
Application granted granted Critical
Publication of ES2347754B1 publication Critical patent/ES2347754B1/es
Publication of ES2347754B8 publication Critical patent/ES2347754B8/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Suspensión oral de lisinato de ibuprofeno.#La presente invención se refiere a una composición farmacéutica a base de lisinato de ibuprofeno en forma de suspensión oral y al procedimiento de preparación de la misma.
ES200901093A 2009-04-27 2009-04-27 Suspension oral de lisinato de ibuprofeno Expired - Fee Related ES2347754B8 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES200901093A ES2347754B8 (es) 2009-04-27 2009-04-27 Suspension oral de lisinato de ibuprofeno
US13/266,730 US20120101159A1 (en) 2009-04-27 2010-04-27 Ibuprofen lysinate oral suspension
PCT/ES2010/000185 WO2010125212A1 (es) 2009-04-27 2010-04-27 Suspensión oral de lisinato de ibuprofeno
TW099113307A TW201038296A (en) 2009-04-27 2010-04-27 Ibuprofen lysinate oral suspension
CN2010800226440A CN102448499A (zh) 2009-04-27 2010-04-27 赖氨酸布洛芬口服混悬剂
JP2012507789A JP5977672B2 (ja) 2009-04-27 2010-04-27 イブプロフェンリシナートの経口投与用の懸濁液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200901093A ES2347754B8 (es) 2009-04-27 2009-04-27 Suspension oral de lisinato de ibuprofeno

Publications (3)

Publication Number Publication Date
ES2347754A1 ES2347754A1 (es) 2010-11-03
ES2347754B1 ES2347754B1 (es) 2011-09-29
ES2347754B8 true ES2347754B8 (es) 2012-06-04

Family

ID=42983234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200901093A Expired - Fee Related ES2347754B8 (es) 2009-04-27 2009-04-27 Suspension oral de lisinato de ibuprofeno

Country Status (1)

Country Link
ES (1) ES2347754B8 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2775648A1 (es) * 2018-04-06 2020-07-27 Mmc Int Health Holding S L Composición farmacéutica en forma de solución oral de la sal de ibuprofeno con lisina
WO2021105524A1 (es) * 2019-11-25 2021-06-03 Mmc International Health Holding, S.L. Composición farmacéutica de la sal de ibuprofeno con lisina en forma de solución oral

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1264857B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
JP2003104881A (ja) * 2001-09-28 2003-04-09 Taiho Yakuhin Kogyo Kk 内服用懸濁液剤

Also Published As

Publication number Publication date
ES2347754B1 (es) 2011-09-29
ES2347754A1 (es) 2010-11-03

Similar Documents

Publication Publication Date Title
CY2018030I1 (el) Φαρμακοτεχνικη μορφη 514
BRPI1012004A2 (pt) "forma farmacêutica"
BRPI0920082A2 (pt) forma de dosagem oral de acetaminofeno/tramadol com liberação estendida.
HUE058971T2 (hu) RSV F fehérjekészítmények és eljárások azok elõállítására
PT2405942T (pt) Produto de administração oral
EP2251005A4 (en) Orally disintegrating tablets
ZA201003688B (en) Arginine salts and their uses for thr treatment of illnesses in the oral cavity
LT3061445T (lt) Labai koncentruotos farmacinės kompozicijos
DK2420223T3 (da) Vandige farmaceutiske sammensætninger med borat-polyol-komplekser
BRPI0912161A2 (pt) composição farmacêutica na forma de um tablete
ITMI20081085A1 (it) Metodo per la preparazione di silicio di grado metallurgico di elevata purezza.
FR2960232B1 (fr) Forme de bombage alveolaire
PL2379086T3 (pl) Preparat farmeceutyczny
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
FI20085310L (fi) Kuumasaumaamalla suljettu pakkaus sekä sen muodostamiseen tarkoitettu pakkausaihio
EP2453031A4 (en) MAGNESIUM ALLOY PLATE
SMT201400053B (it) Forme farmaceutiche orali di bendamustina
EP2263661A4 (en) ORAL PREPARATION
EP2413951A4 (en) FORMULATION FOR GENERATING A WIDE REACTIVE NEUTRALIZATION OF HIV ANTIBODIES
BRPI1014821A2 (pt) "inibidores de replicação de hiv"
PL2271348T3 (pl) Doustny preparat związków tetracyklinowych w postaci tabletki
GB0815972D0 (en) Pharmaceutical preparation
EP2343059A4 (en) ORAL PREPARATION
CR20130572A (es) Formulaciones de liberación sostenida de paracetamol
ES2347754B8 (es) Suspension oral de lisinato de ibuprofeno

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20101103

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2347754

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20110929

FD2A Announcement of lapse in spain

Effective date: 20210928